Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable Trust Distinguished ...

Prostate cancer and other cancers characterized by “cold” tumors could become more responsive to checkpoint blockade if UBA1 is inhibited.

Glioblastoma is the deadliest form of brain cancer, with less than a 5% five-year survival rate. One of the key contributors ...

Recent advances in immunotherapy research have revealed crucial roles for new immune cells in combating cancer, leading to ...

Work supported by: This research was funded by a sponsored research agreement from Inovio Pharmaceuticals. Dr. David B. Weiner is supported by the W.W. Smith Charitable Trust Professorship in Cancer ...

A study from the University of Michigan Health Rogel Cancer Center may have—at last—cracked the cold case of immunotherapy ...

A doctor found himself not only a patient, but the first patient in the world to undergo a procedure that saved his life.

US scientists have developed a new CRISPR toolkit to boost the treatment of genetic disorders. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a Nobel Prize-winning gene-editing ...

Advancements in cancer treatments like chemotherapy, immunotherapy, radiation, transplants and surgery have allowed more and more children to survive their diseases. But the same treatments that are ...

A new review was published in Oncotarget's Volume 15 on November 22, 2024, entitled "Mesenchymal stem cells – the secret agents of cancer immunotherapy: Promises, challenges, and surprising twists." ...